← Back to Search

experimental for Rheumatoid Arthritis

N/A
Waitlist Available
Led By Keri LeCompte, PharmD
Research Sponsored by Blue Cross Blue Shield of Vermont
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

Study Summary

This trial is testing whether a lifestyle intervention can improve RA treatment when used alongside standard best practices.

Eligible Conditions
  • Rheumatoid Arthritis
  • Lifestyle Risk Reduction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HAQ-2 score
Body Weight Changes
Secondary outcome measures
Change in BMI
Change in RA-related costs for the study participant
Change in RA-related costs to the insurer
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: experimentalExperimental Treatment1 Intervention
standard of care + lifestyle intervention
Group II: controlActive Control1 Intervention
no intervention (control group)

Find a Location

Who is running the clinical trial?

Blue Cross Blue Shield of VermontLead Sponsor
Keri LeCompte, PharmDPrincipal InvestigatorBlue Cross Blue Shield of Vermont

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a current call for participants in this trial?

"As confirmed on clinicaltrials.gov, this experiment is no longer enrolling patients; it was initially listed on the 1st of January 2023 and last updated on September 22nd 2022. Despite its closure, 391 other trials have opened their doors to volunteers presently."

Answered by AI

What aims are being sought with this clinical experiment?

"The main goal of this trial, which will be measured for a period up to two years, is to record the alteration in C-Reactive Protein levels. Other objectives involve noting changes in the medications required to treat RA (Number of Medications Taken Specifically for Rheumatoid arthritis), any elevation in serum total cholesterol (Elevated Total Cholesterol linked with cardiac issues) and fluctuations in blood pressure (Blood Pressure Change)."

Answered by AI

Who else is applying?

What state do they live in?
California
Pennsylvania
How old are they?
65+
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Want to know more about arthritis.
PatientReceived 2+ prior treatments
~53 spots leftby Mar 2025